Hong Kong Drug Regulators To Step Up Inspections To Improve Drug Safety
This article was originally published in PharmAsia News
Executive SummaryHONG KONG - Hong Kong regulators may step up inspections of drug manufacturing facilities outside the former British enclave following a series of recommendations in December to improve drug safety
You may also be interested in...
Major changes are afoot in Hong Kong’s drug approval and regulatory process with safety a prime focus following a series of reforms implemented last year in response to six deaths from spurious generic drugs in 2009.
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).